Cargando…

Long non-coding RNA-based signatures to improve prognostic prediction of breast cancer

Breast cancer (BC) is a disease of high mortality rate because of high malignant, while early diagnosis and personal management may make a better prognosis possible. This study aimed to establish and validate lncRNAs signatures to improve the prognostic prediction for BC. RNA sequencing data along w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yi, Wang, Yuzhi, Tian, Gang, Jiang, Tianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535645/ https://www.ncbi.nlm.nih.gov/pubmed/33019395 http://dx.doi.org/10.1097/MD.0000000000022203

Ejemplares similares

Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis
por: Zhang, Shuo, et al.
Publicado: (2020)

Construction and validation of a transient receptor potential-related long noncoding RNA signature for prognosis prediction in breast cancer patients
por: Guo, Qiaonan, et al.
Publicado: (2023)

Identification of an optimized glycolytic-related risk signature for predicting the prognosis in breast cancer using integrated bioinformatic analysis
por: Jiang, Di, et al.
Publicado: (2023)

A senescence-related signature for predicting the prognosis of breast cancer: A bioinformatics analysis
por: Xing, Tengfei, et al.
Publicado: (2023)

Establishment of a 6-signature risk model associated with cellular senescence for predicting the prognosis of breast cancer
por: Zhang, Xiu-Xia, et al.
Publicado: (2023)

The effects of LncRNA PVT1 on clinical characteristics and survival in breast cancer patients: A protocol for systematic review and meta analysis
por: Xie, Li, et al.
Publicado: (2021)

Genetic Polymorphisms in Long Noncoding RNA H19 Are Associated With Susceptibility to Breast Cancer in Chinese Population
por: Xia, Zongjiang, et al.
Publicado: (2016)

Prognostic value of programmed cell death ligand-1 expression in breast cancer: A meta-analysis
por: Zhang, Yingzi, et al.
Publicado: (2020)

Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy
por: Cao, Lu, et al.
Publicado: (2016)

Prognostic nomogram for female patients suffering from non-metastatic Her2 positive breast cancer: A SEER-based study
por: Wu, Jiangwen, et al.
Publicado: (2022)

Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis
por: Liu, Xu, et al.
Publicado: (2017)

Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database
por: Chen, Bing, et al.
Publicado: (2023)

Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer
por: Sjekloča, Nikoleta, et al.
Publicado: (2020)

Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer
por: Yu, Ziyi, et al.
Publicado: (2023)

Non-islet cell tumor hypoglycemia caused by breast tumor: A case report
por: Zhou, Zhibing, et al.
Publicado: (2021)

High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancer
por: Li, Yanqing, et al.
Publicado: (2019)

Comprehensive analysis of NT5DC family prognostic and immune significance in breast cancer
por: Jia, Yiwei, et al.
Publicado: (2023)

ANO6 is a reliable prognostic biomarker and correlates to macrophage polarization in breast cancer
por: Tang, Long-Huan, et al.
Publicado: (2023)

In silico screening using bulk and single-cell RNA-seq data identifies RIMS2 as a prognostic marker in basal-like breast cancer: A retrospective study
por: Zhang, Lingyun, et al.
Publicado: (2021)

Utility of Red Cell Distribution Width as a Prognostic Factor in Young Breast Cancer Patients
por: Huang, Du-Ping, et al.
Publicado: (2016)

Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis
por: Sun, Xi, et al.
Publicado: (2017)

Exploring immune-related genes with prognostic value in microenvironment of breast cancer from TCGA database
por: Yang, Hao, et al.
Publicado: (2020)

Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma
por: He, Qiang, et al.
Publicado: (2021)

Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis
por: Ding, Yunfeng, et al.
Publicado: (2021)

Prognostic significance of lymphatic vessel invasion diagnosed by D2-40 in Chinese invasive breast cancers
por: He, Ke-Wen, et al.
Publicado: (2017)

Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis
por: Yang, Yiming, et al.
Publicado: (2017)

Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis
por: Park, Soyeon, et al.
Publicado: (2017)

Prognostic significance of preoperative albumin to fibrinogen ratio associated nomograms in patients with breast invasive ductal carcinoma
por: Zheng, Lihua, et al.
Publicado: (2020)

Dynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer
por: Choi, Eun Jung, et al.
Publicado: (2016)

Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study
por: Wen, Jiahuai, et al.
Publicado: (2015)

Identification of prognostic genes for early basal-like breast cancer with weighted gene co-expression network analysis
por: Yuan, Keyu, et al.
Publicado: (2022)

Prognostic significance of TP53 and PIK3CA mutations analyzed by next-generation sequencing in breast cancer
por: Choi, Jin Hyuk, et al.
Publicado: (2023)

Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc
por: Cui, Jianxiu, et al.
Publicado: (2019)

CONSORT-Independent prognostic value of asphericity of pretherapeutic F-18 FDG uptake by primary tumors in patients with breast cancer
por: Jung, Ji-hoon, et al.
Publicado: (2017)

Positive estrogen receptor status is a poor prognostic factor in node-negative breast cancer: An observational study in Asian patients
por: Jung, Eun Jung, et al.
Publicado: (2021)

Development and validation of a risk stratification nomogram for predicting prognosis in bone metastatic breast cancer: A population-based study
por: Hou, Niuniu, et al.
Publicado: (2021)

Prognostic significance of molecular subtype, metastatic site and primary tumor surgery for survival in primary metastatic breast cancer: A SEER-based study
por: Li, Yang, et al.
Publicado: (2021)

Estrogen Receptor Status Predicts Late-Onset Skeletal Recurrence in Breast Cancer Patients
por: Han, Hyun Ho, et al.
Publicado: (2016)

The efficacy of gefitinib supplementation for breast cancer: A meta-analysis of randomized controlled studies
por: Ye, Jing, et al.
Publicado: (2020)

Identification of breast cancer-related circRNAs by analysis of microarray and RNA-sequencing data: An observational study
por: Zhao, Chun-Hua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4fjvd2v3pr1utcbb8ngib31eie